Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
University of Chicago
University of Chicago
University of Chicago
University of Chicago
University of Chicago
University of Chicago
University of Chicago
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)